Ellsworth Advisors LLC Purchases New Shares in Electromed, Inc. (NYSE:ELMD)

Ellsworth Advisors LLC bought a new position in Electromed, Inc. (NYSE:ELMD - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 24,834 shares of the company's stock, valued at approximately $734,000. Ellsworth Advisors LLC owned 0.29% of Electromed at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in ELMD. Navellier & Associates Inc. acquired a new stake in shares of Electromed in the third quarter worth $368,000. State Street Corp lifted its position in Electromed by 14.5% during the 3rd quarter. State Street Corp now owns 22,066 shares of the company's stock worth $474,000 after acquiring an additional 2,800 shares in the last quarter. Barclays PLC acquired a new position in shares of Electromed during the third quarter worth $215,000. Walleye Capital LLC purchased a new position in shares of Electromed in the third quarter valued at $274,000. Finally, Legacy Wealth Asset Management LLC acquired a new stake in Electromed during the 4th quarter valued at $253,000. Institutional investors and hedge funds own 40.82% of the company's stock.

Insider Buying and Selling

In other Electromed news, Director Andrew Summers sold 17,463 shares of the business's stock in a transaction dated Monday, December 2nd. The shares were sold at an average price of $30.09, for a total transaction of $525,461.67. Following the sale, the director now directly owns 189,838 shares in the company, valued at approximately $5,712,225.42. The trade was a 8.42 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 14.00% of the company's stock.

Analyst Upgrades and Downgrades

Separately, StockNews.com lowered Electromed from a "strong-buy" rating to a "buy" rating in a research report on Thursday, January 9th.

Electromed Price Performance

ELMD traded up $0.13 during trading hours on Monday, hitting $34.00. 79,128 shares of the stock were exchanged, compared to its average volume of 76,680. Electromed, Inc. has a 12 month low of $9.90 and a 12 month high of $34.25. The stock has a 50-day simple moving average of $29.57 and a 200-day simple moving average of $22.32. The stock has a market cap of $287.64 million, a price-to-earnings ratio of 47.22 and a beta of 0.31.

Electromed (NYSE:ELMD - Get Free Report) last released its quarterly earnings data on Tuesday, November 12th. The company reported $0.16 earnings per share for the quarter, topping the consensus estimate of $0.03 by $0.13. Electromed had a net margin of 11.34% and a return on equity of 15.32%. The firm had revenue of $14.67 million for the quarter.

Electromed Company Profile

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions.